Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Small, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin ...

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...

Medically reviewed by Do-Eun Lee, MD Changing diabetes medications isn't something you should take lightly. ... This is especially true if you are managing your blood sugar with your current drugs.